Dr. Othman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673
Education & Training
- Rush Medical College of Rush University Medical CenterClass of 2017
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma.Tamer Othman, Paul Frankel, Pamela Allen, Leslie L Popplewell, Geoffrey Shouse
Haematologica. 2025-01-01 - A phase I trial of CC-486, lenalidomide, obinutuzumab in relapsed/refractory indolent non-Hodgkin lymphoma.Tamer Othman, Gabriel Marquez-Arreguin, Naseem Esteghamat, Joseph Tuscano
Leukemia & Lymphoma. 2024-12-28 - 1 citationsImpact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leuke...Talha Badar, Ravi Narra, Alice S Mims, Michael G Heckman, Rory M Shallis
American Journal of Hematology. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: